NCT01731730View on ClinicalTrials.gov

Study to Evaluate Safety/Efficacy of a Single Pre-Op Dose of AYX1 Injection to Treat Pain After Knee Replacement Surgery

PHASE2CompletedINTERVENTIONAL

Enrollment

102

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

October 31, 2013

Study Completion Date

November 30, 2013

Conditions

Postsurgical Pain

Interventions

DRUG

Placebo Injection

3mL solution for intrathecal injection; Vehicle formulation designed to mimic AYX1 Injection (with no active drug)

DRUG

AYX1 Injection 110 mg

3mL solution for intrathecal injection with 110 mg of AYX1

DRUG

AYX1 Injection 330 mg

3mL solution for intrathecal injection with 330 mg of AYX1

Trial Locations (7)

Unknown

Sheffield

Phoenix

Boynton Beach

Altoona

Houston

Nassau Bay

Odessa

All Listed Sponsors

lead

Adynxx, Inc.

INDUSTRY

NCT01731730 - Study to Evaluate Safety/Efficacy of a Single Pre-Op Dose of AYX1 Injection to Treat Pain After Knee Replacement Surgery | Biotech Hunter | Biotech Hunter